Back to search results
NCT05075967

Getting to Zero Among HHI MSM in the American South

Enrolling by Invitation
NAAges 15+InterventionalPrevention
HIV Prevention Trials Network
~2,700 participants
Updated 2026-03-13 on ClinicalTrials.gov
What's tested:Health Access CoalitionsSocial MediaPeer SupportPromoting Human Autonomy Support & Empathy (PHASE)

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
To evaluate whether the HPTN 096 integrated strategy increases the number of HHI MSM clients at PHASE healthcare facilities.
Measured over Month 12
+2 more outcomes measured

Conditions

HIV Infections

Explore related trials

HIV Infection

Where it's being run

1 sites across 1 states
North Carolina1

Study leadership

  • LaRon Nelson, PhD · STUDY_CHAIR · Yale University School of Nursing
  • Chris Beyrer, MD · STUDY_CHAIR · Duke University

Who to contact

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

At least 18 years of age
Man
Self-reports a lifetime history of anal sex with another man (i.e., at any time in their life)
Determined to be HHI within the study community per Centers for Disease Control and Prevention surveillance data
Willing and able to provide consent to participate in the study
Have a medical visit scheduled during the designated sampling period at a PHASE treatment or prevention healthcare facility
Completed the cross-sectional HHI MSM client assessment
Willing and able to provide assent/consent
Is a staff member at a participating PHASE facility
Participated in at least one PHASE activity (e.g., attended a PHASE Foundation training, participated in Extension of Community Healthcare Outcomes training, member of PHASE quality improvement team)
Willing and able to provide consent

What this trial measures

  • To evaluate whether the HPTN 096 integrated strategy increases the number of HHI MSM clients at PHASE healthcare facilities.Month 12

    Number of HHI MSM with a visit at the HCF in the previous 12 months (Source: EMR).

  • To evaluate whether the HPTN 096 integrated strategy increases retention in care among HHI MSM living with HIV at PHASE healthcare facilities.Month 12

    Number of HHI MSM living with HIV with at least two HIV medical visits to the HCF at least 90 days apart within the previous 12 months (Source: EMR)

  • To evaluate whether the HPTN 096 integrated strategy increases PrEP prescriptions for HHI MSM not living with HIV at PHASE healthcare facilities.Month 12

    Any PrEP prescription among all HHI MSM without HIV with a medical visit at the HCF within the previous 12 months (Source: EMR).